Журнал "Почки" том 8, №4

Îãëÿä / Review
cation: comparison to conventional 51Cr-EDTA. J Nucl Med. 2015.
Vol. 56. P. 405-409. https://doi.org/10.2967/jnumed.114.147843.
15. Hofman M.S., Hicks R.J. Gallium-68 EDTA PET/CT for
renal imaging. Semin. Nucl. Med. 2016. Vol. 46. P. 448-461. doi:
10.1053/j.semnuclmed.2016.04.002.
16. Hofman M.S., Violet J., Hicks R.J. et al. [(177)Lu]-PS-
MA-617 radionuclide treatment in patients with metastatic castration-resistant
prostate cancer (LuPSMA trial): a single-centre, singlearm,
phase 2 study. Lancet Oncol. 2018. Vol. 19. P. 825-833. Doi:
10.1016/S1470-2045(18)30198-0.
17. Inker L.A., Schmid C.H., Tighiouart H. et al. Estimating glomerular
filtration rate from serum creatinine and cystatin. N. Engl. J. Med.
2012. Vol. 367. P. 20-29. https:// doi.org/10.1056/NEJMoa1114248.
18. Inoue Y., Yoshikawa К., Suzuki Т. et al. Attenuation correction
in evaluating renal function in children and adults by a camerabased
method. J. Nucl. Med. 2000. Vol. 41. P. 823-829.
19. Jackson P., Foroudi F., Pham D. et al. Short communication:
timeline of radiation-induced kidney function loss after stereotactic
ablative body radiotherapy of renal cell carcinoma as evaluated
by serial (99m)Tc-DMSA SPECT/CT. Radiat. Oncol. 2014. Vol. 9.
P. 253. doi: 10.1186/s13014-014-0253-z.
20. Klenc J., Taylor А., Lipowska М. Synthesis and evaluation of
99mTc(CO)3(FEDA): a new dual-purpose 99mTc/18F renal imaging
agent. J. Nucl. Med. 2015. Vol. 56. Suppl. 3. P. 654.
21. Klopper J.F., Hauser W., Atkins H.L. et al. Evaluation of 99m
Tc-DTPA for the measurement of glomerular filtration rate. J. Nucl.
Med. 1972. Vol. 13. P. 107-110.
22. Kobayashi R., Chen Х., Werner R.A. et al. New horizons in
cardiac innervationimaging: introduction ofnovel (18)F-labeled PET
tracers. Eur. J. Nucl. Med. Mol. Imaging. 2017. Vol. 44. P. 2302-
2309. Doi: 10.1007/s00259-017-3828-8.
23. Korol P., Tkachenko М. The role of radioactive methods in
the diagnostic type of hydronephrosis in clean-up workers of chornodil
accident. Problems of radiation medicine and radiobiology. 2018. Vol.
23. P. 351-358.
24. Kundin V., Pospelov S. Dynamic renoscintigraphy in urjljgical
practice. Urology. 2012. Vol. 16. № 4. P. 5-24.
25. Li Z.B., Wu Z., Cao Q. et al. The synthesis of 18F-FDS and
its potential application in molecular imaging. Mol. Imaging. Biol.
2008. Vol. 10. P. 92-98. Doi: 10.1007/s11307-007-0125-0.
26. Li J., Zheng Н., Fodah R. Validation of 2-(18)F-fluorodeoxysorbitol
as a potential radiopharmaceutical for imaging bacterial
infection in the lung. J. Nucl. Med. 2018. Vol. 59. P. 134-139. Doi:
org/10.2967/jnumed.117.195420.
27. Lipowska M., Jarkas N., Voll R.J. et al. Re(CO)3([18F]
FEDA), a novel (18)F PET renal tracer: radiosynthesis and preclinical
evaluation. Nucl. Med. Biol. 2018. Vol. 58. P. 42-50. Doi:
10.1016/j.nucmedbio.2017.12.001.
28. Lipowska M., Klenc J., Jarkas N. et al. Monoanionic (99m)
Tc-tricarbonyl-aminopolycarboxylate complexes with uncharged pendant
groups: radiosynthesis and evaluation as potential renal tubular
tracers. Nucl. Med. Biol. 2017. Vol. 47. P. 48-55. Doi: 10.1016/j.nucmedbio.2016.12.008.
29. Lipowska M., Klenc J., Shetty D. et al. Al18F-NODA-butyric
acid: biological evaluation of a new PET renal radiotracer.
Nucl. Med. Biol. 2014. Vol. 41. P. 248-253. Doi: 10.1016/j.nucmedbio.2013.12.010.
30. Ma Y.C., Zuo L., Zhang C.L. et al. Comparison of 99mTc-
DTPA renal dynamic imaging with modified MDRD equation for glomerular
filtration rate estimation in Chinese patients in different stages
of chronic kidney disease. Nephrol. Dial. Trаnsplant. 2007. Vol. 22.
P. 417-423. Doi: 10.1093/ndt/gfl603.
31. Matsushita K., van der Velde М., Astor В.С. et al. Associationof
estimated glomerular filtration rate and albuminuria with allcause
and cardiovascular mortality in general population cohorts: a
collaborative meta-analysis. Lancet. 2010. Vol. 375. P. 2073-2081.
doi: org/10.1016/S0140-6736(10)60674-5.
32. Maurer S., Herhaus Р., Lippenmeyer R. Side effects of CXCchemokine
receptor 4-directed endoradiotherapy with pentixather
prior to hematopoietic stem cell transplantation. J. Nucl. Med. 2019.
Doi: 10.2967/jnumed.118.223420.
33. Pathuri G., Hedrick А., Awasthi V. et al. Evaluation of Para-18F-fluorohippurate
PET renography to predict future disease
progression in a rat model of ADPKD. J. Nucl. Med. 2015. Vol. 56.
P. 1077.
34. Pathuri G., Sahoo К., Awasthi V. et al. Renogram comparison
of p-(18)F]fluorohippurate with o-[(125)I] iodohippurate and [(99m)
Tc]MAG3 in normal rats. Nucl. Med. Commun. 2011. Vol. 32. P. 908-
912. Doi: 10.1097/MNM.0b013e32834a6db6.
35. Qin Z., Hoh C.K., Olson E.S. et al. Molecular imaging of
the glomerulus via mesangial cell uptake of radiolabeled tilmanocept.
J. Nucl. Med. 2019. doi: 10.2967/jnumed.118.223727.
36. Rehling M., Nielsen L.E., Marqversen J. Protein binding of
99Tc-DTPA compared with other GFR tracers. Nucl. Med. Commun.
2001. Vol. 22. P. 617-623.
37. Rehling M. Stability, protein binding and clearance studies
of [99mTc]DTPA. Evaluation of a commercially available dry-kit.
Scand. J. Clin. Lab. Invest. 1988. Vol. 48. P. 603-609.
38. Sanchez-Crespo A. Comparison of gallium-68 and fluorine-18imaging
characteristics in positron emission tomography.
Appl. Radiat. Isot. 2013. Vol. 76. P. 55-62. doi: 10.1016/j.apradiso.2012.06.034.
39. Schaer L.R., Anger Н.О., Gottschalk А. Gallium edetate
68Ga experiences in brain-lesion detection with the positron camera.
JAMA. 1966. Vol. 198. P. 811-813.
40. Shokeir A.A., Gad H.M., el-Diasty T. Role of radioisotope
renal scans in the choice of nephrectomy side in live kidney
donors. Jurol. 2003. Vol. 170. P. 373-376. Doi: 10.1097/01.
ju.0000074897.48830.58.
41. Smith W.W., Finkelstein N., Smith N.F. et al. Renal excretion
of hexitols (sorbitol, mannitol, and dulcitol) and their derivatives
(sorbitan, isomannide, and sorbide) and of endogenous creatinine-like
chromogen in dog and man. J. Biol. Chem. 1940. Vol. 135. P. 231-250.
42. Sobh M., Neamatallah А., Sheashaa Н. Sobh formula: a new
formula for estimation of creatinine clearance in healthy subjects and
patients with chronic renal disease. Int. Urol. Nephrol. 2005. Vol. 37.
P. 403-408. doi: 10.1007/s11255-004-1262-x.
43. Soveri I., Berg U.B., Bjork J. et al. Measuring GFR: a systematic
review. Am. J. Kidney Dis. 2014. Vol. 64. P. 5.
44. Strosberg J., El-Haddad G., Wolin Е. et al. Phase 3 trial
of (177)Lu-Dotatate for midgut neuroendocrine tumors. N. Engl. J.
Med. 2017. Vol. 376. P. 125-135. Doi: 10.1056/NEJMoa1607427.
45. Szabo Z., Xia J., Mathews W.B. et al. Future direction of renal
positron emission tomography. Semin. Nucl. Med. 2006. Vol. 36.
P. 36-50. Doi: 10.1053/j.semnuclmed.2005.08.003.
46. Taylor A.T. Radionuclides in nephrourology, part 1: radiopharmaceuticals,
quality control, and quantitative indices. J. Nucl.
Med. 2014. Vol. 55. P. 608-615. Doi: 10.2967/jnumed.113.133447.
76 Íèðêè, ISSN 2307-1257 (print), ISSN 2307-1265 (online) Òîì 8, ¹ 4, 2019